[
  {
    "title": "Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks",
    "published": 1742806869,
    "posting_price": 209.38999939,
    "close_price": 208.55999756,
    "percent_change": -0.39639039
  },
  {
    "title": "J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease",
    "published": 1742560080,
    "posting_price": 211.72999573,
    "close_price": 210.00999451,
    "percent_change": -0.81235595
  },
  {
    "title": "3 Dividend Stocks to Buy for Reliable Passive Income",
    "published": 1742383800,
    "posting_price": 214.02999878,
    "close_price": 212.25,
    "percent_change": -0.83165855
  },
  {
    "title": "AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancer",
    "published": 1742207191,
    "posting_price": 212.22000122,
    "close_price": 214.47000122,
    "percent_change": 1.06022052
  },
  {
    "title": "1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction",
    "published": 1742163540
  },
  {
    "title": "Q4 2024 Regenxbio Inc Earnings Call",
    "published": 1741959544,
    "posting_price": 209.77999878,
    "close_price": 211.77000427,
    "percent_change": 0.94861546
  },
  {
    "title": "Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.",
    "published": 1741944600,
    "posting_price": 209.77999878,
    "close_price": 211.77000427,
    "percent_change": 0.94861546
  },
  {
    "title": "Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo Nordisk stock slides 4%",
    "published": 1741795343,
    "posting_price": 212.0,
    "close_price": 212.05999756,
    "percent_change": 0.02830074
  },
  {
    "title": "AbbVie's Options Frenzy: What You Need to Know",
    "published": 1713184680,
    "posting_price": 160.22003612,
    "close_price": 157.44451904,
    "percent_change": -1.73231585
  },
  {
    "title": "Roche reports survival data for new dual-acting lymphoma drug",
    "published": 1713182220,
    "posting_price": 160.22003612,
    "close_price": 157.44451904,
    "percent_change": -1.73231585
  },
  {
    "title": "AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant for Preventive Treatment of Migraine",
    "published": 1713176025,
    "posting_price": 160.22003612,
    "close_price": 157.44451904,
    "percent_change": -1.73231585
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds AbbVie",
    "published": 1713168360,
    "posting_price": 160.22003612,
    "close_price": 157.44451904,
    "percent_change": -1.73231585
  },
  {
    "title": "Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug",
    "published": 1713158409,
    "posting_price": 160.22003612,
    "close_price": 157.44451904,
    "percent_change": -1.73231585
  },
  {
    "title": "AbbVie Stock (NYSE:ABBV): Humira Leads Market with 96% Share",
    "published": 1713144660,
    "posting_price": 160.22003612,
    "close_price": 157.44451904,
    "percent_change": -1.73231585
  },
  {
    "title": "AbbVie: Great To Be Proven Wrong - Still Not A Buy",
    "published": 1713088800
  },
  {
    "title": "BME: Discount Widens Substantially Creating An Opportunity",
    "published": 1713085944
  },
  {
    "title": "Is AbbVie a Millionaire Maker?",
    "published": 1713072180
  },
  {
    "title": "AbbVie keeps Humira market share near 100% despite biosimilars: report",
    "published": 1713002160
  },
  {
    "title": "What's Going On AbbVie Stock On Friday?",
    "published": 1712953194,
    "posting_price": 160.15184086,
    "close_price": 158.03855896,
    "percent_change": -1.31954893
  },
  {
    "title": "Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors",
    "published": 1712937726,
    "posting_price": 160.15184086,
    "close_price": 158.03855896,
    "percent_change": -1.31954893
  },
  {
    "title": "AbbVie: Bulletproof Fundamentals",
    "published": 1712931054,
    "posting_price": 160.15184086,
    "close_price": 158.03855896,
    "percent_change": -1.31954893
  },
  {
    "title": "Law Offices of Howard G. Smith Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors",
    "published": 1712930046,
    "posting_price": 160.15184086,
    "close_price": 158.03855896,
    "percent_change": -1.31954893
  },
  {
    "title": "AbbVie: Despite The Run, Shares Still Look Attractive, Yielding 3.67%",
    "published": 1712921755,
    "posting_price": 160.15184086,
    "close_price": 158.03855896,
    "percent_change": -1.31954893
  },
  {
    "title": "AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA\u00ae) for Preventive Treatment of Migraine",
    "published": 1712921400,
    "posting_price": 160.15184086,
    "close_price": 158.03855896,
    "percent_change": -1.31954893
  },
  {
    "title": "GLP-1s benefit Parkinson\u2019s: Barclays sees implications across biopharma",
    "published": 1712919780,
    "posting_price": 160.15184086,
    "close_price": 158.03855896,
    "percent_change": -1.31954893
  },
  {
    "title": "AbbVie Enters Oversold Territory",
    "published": 1712918280,
    "posting_price": 160.15184086,
    "close_price": 158.03855896,
    "percent_change": -1.31954893
  },
  {
    "title": "AbbVie hails positive results for chronic migraine prevention",
    "published": 1712913900,
    "posting_price": 160.15184086,
    "close_price": 158.03855896,
    "percent_change": -1.31954893
  },
  {
    "title": "Smart Money Is Betting Big In ABBV Options",
    "published": 1712913000,
    "posting_price": 160.15184086,
    "close_price": 158.03855896,
    "percent_change": -1.31954893
  },
  {
    "title": "Biogen Is Suffering From Doubts About the Future",
    "published": 1712908860,
    "posting_price": 160.15184086,
    "close_price": 158.03855896,
    "percent_change": -1.31954893
  },
  {
    "title": "Here It Is! My 20-Stock 6-Figure Market-Beating Dividend Portfolio",
    "published": 1712905200,
    "posting_price": 160.15184086,
    "close_price": 158.03855896,
    "percent_change": -1.31954893
  },
  {
    "title": "AbbVie presents results from ongoing Phase 3 study of oral atogepant",
    "published": 1712903580,
    "posting_price": 160.15184086,
    "close_price": 158.03855896,
    "percent_change": -1.31954893
  },
  {
    "title": "AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors",
    "published": 1712871919,
    "posting_price": 163.2530713,
    "close_price": 161.63212585,
    "percent_change": -0.99290349
  },
  {
    "title": "Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024",
    "published": 1712855422,
    "posting_price": 163.2530713,
    "close_price": 161.63212585,
    "percent_change": -0.99290349
  },
  {
    "title": "What Vertex Pharmaceuticals Is Getting With Acquisition Of Alpine Immune Sciences",
    "published": 1712849028,
    "posting_price": 163.2530713,
    "close_price": 161.63212585,
    "percent_change": -0.99290349
  },
  {
    "title": "AbbVie Inc's Dividend Analysis",
    "published": 1712833335,
    "posting_price": 163.2530713,
    "close_price": 161.63212585,
    "percent_change": -0.99290349
  },
  {
    "title": "May 31st Options Now Available For AbbVie (ABBV)",
    "published": 1712830680,
    "posting_price": 163.2530713,
    "close_price": 161.63212585,
    "percent_change": -0.99290349
  },
  {
    "title": "The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today",
    "published": 1712825520,
    "posting_price": 163.2530713,
    "close_price": 161.63212585,
    "percent_change": -0.99290349
  },
  {
    "title": "Alkermes' Innovations Are Transforming Mental Health Treatments",
    "published": 1712822460,
    "posting_price": 163.2530713,
    "close_price": 161.63212585,
    "percent_change": -0.99290349
  },
  {
    "title": "Are You Looking for a High-Growth Dividend Stock?",
    "published": 1712763907,
    "posting_price": 162.66451275,
    "close_price": 163.08905029,
    "percent_change": 0.26098965
  },
  {
    "title": "AbbVie Is \u2018One of the Best Positioned\u2019 Large Cap Stocks",
    "published": 1712760780,
    "posting_price": 162.66451275,
    "close_price": 163.08905029,
    "percent_change": 0.26098965
  },
  {
    "title": "The Law Offices of Frank R. Cruz Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors",
    "published": 1712760365,
    "posting_price": 162.66451275,
    "close_price": 163.08905029,
    "percent_change": 0.26098965
  },
  {
    "title": "Syros (SYRS) Up on FDA Fast Track Tag for Tamibarotene in AML",
    "published": 1712756940,
    "posting_price": 162.66451275,
    "close_price": 163.08905029,
    "percent_change": 0.26098965
  },
  {
    "title": "The Zacks Analyst Blog Highlights AbbVie, Salesforce, General Electric, The TJX Companies and UBS Group",
    "published": 1712754180,
    "posting_price": 162.66451275,
    "close_price": 163.08905029,
    "percent_change": 0.26098965
  },
  {
    "title": "Buy Rating on AbbVie: Resilient Humira Market Position and Promising Pipeline Outlook",
    "published": 1712733960,
    "posting_price": 162.66451275,
    "close_price": 163.08905029,
    "percent_change": 0.26098965
  },
  {
    "title": "AbbVie pullback brings attractive entry point, says JPMorgan",
    "published": 1712729160,
    "posting_price": 162.66451275,
    "close_price": 163.08905029,
    "percent_change": 0.26098965
  },
  {
    "title": "Analysts Conflicted on These Healthcare Names: Conmed (CNMD), AbbVie (ABBV) and Nurix Therapeutics (NRIX)",
    "published": 1712722260,
    "posting_price": 162.66451275,
    "close_price": 163.08905029,
    "percent_change": 0.26098965
  },
  {
    "title": "Blindness-Focused LENZ Therapeutics' Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst Says",
    "published": 1712715720,
    "posting_price": 162.66451275,
    "close_price": 163.08905029,
    "percent_change": 0.26098965
  },
  {
    "title": "Top Stock Reports for AbbVie, Salesforce & General Electric",
    "published": 1712688240,
    "posting_price": 163.76445627,
    "close_price": 164.16004944,
    "percent_change": 0.24156229
  },
  {
    "title": "SkinMedica\u00ae Empowers Clear Skin Confidence with a New, Modern Approach to Acne",
    "published": 1712664000,
    "posting_price": 163.76445627,
    "close_price": 164.16004944,
    "percent_change": 0.24156229
  },
  {
    "title": "10 Unstoppable Dividend Stocks To Buy",
    "published": 1712661183,
    "posting_price": 163.76445627,
    "close_price": 164.16004944,
    "percent_change": 0.24156229
  },
  {
    "title": "Is WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now?",
    "published": 1712658005,
    "posting_price": 163.76445627,
    "close_price": 164.16004944,
    "percent_change": 0.24156229
  },
  {
    "title": "Syros jumps on FDA fast track tag for leukemia drug",
    "published": 1712657220,
    "posting_price": 163.76445627,
    "close_price": 164.16004944,
    "percent_change": 0.24156229
  },
  {
    "title": "3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade",
    "published": 1712650860,
    "posting_price": 163.76445627,
    "close_price": 164.16004944,
    "percent_change": 0.24156229
  },
  {
    "title": "Here's Why AbbVie (ABBV) Fell More Than Broader Market",
    "published": 1712613019,
    "posting_price": 163.26272593,
    "close_price": 163.83198547,
    "percent_change": 0.34867698
  },
  {
    "title": "AbbVie: Still Fits Buffett's 10x EBT Rule Well Despite Guidance Revision",
    "published": 1712575516,
    "posting_price": 163.26272593,
    "close_price": 163.83198547,
    "percent_change": 0.34867698
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), AbbVie (ABBV) and Immunome (IMNM)",
    "published": 1712544600,
    "posting_price": 163.26272593,
    "close_price": 163.83198547,
    "percent_change": 0.34867698
  },
  {
    "title": "Analysts Conflicted on These Healthcare Names: AbbVie (ABBV), Universal Health (UHS) and Teladoc (TDOC)",
    "published": 1712543520,
    "posting_price": 163.26272593,
    "close_price": 163.83198547,
    "percent_change": 0.34867698
  },
  {
    "title": "Morgan Stanley sees Fed rate cut fueling biotech stocks",
    "published": 1712493540
  },
  {
    "title": "Morgan Stanley sees Fed rate cut fueling biotech stock performance",
    "published": 1712493180
  },
  {
    "title": "Do These 3 Checks Before Buying AbbVie Inc. (NYSE:ABBV) For Its Upcoming Dividend",
    "published": 1712493127
  },
  {
    "title": "3 No-Brainer Dividend Stocks to Buy in April",
    "published": 1712400540
  },
  {
    "title": "Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why",
    "published": 1712399820
  },
  {
    "title": "Dividend Champion, Contender, And Challenger Highlights: Week Of April 7",
    "published": 1712394285
  },
  {
    "title": "CollPlant Biotechnologies Ltd (CLGN) Q4 2023 Earnings Call Transcript Highlights: A Year of ...",
    "published": 1712353501,
    "posting_price": 162.09524285,
    "close_price": 164.02494812,
    "percent_change": 1.19047619
  },
  {
    "title": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It",
    "published": 1712322016,
    "posting_price": 162.09524285,
    "close_price": 164.02494812,
    "percent_change": 1.19047619
  },
  {
    "title": "AbbVie (NYSE:ABBV) Trims EPS Outlook, Stock Drops",
    "published": 1712320620,
    "posting_price": 162.09524285,
    "close_price": 164.02494812,
    "percent_change": 1.19047619
  },
  {
    "title": "Boehringer Ingelheim to lay off staff amid biosimilar challenges",
    "published": 1712318400,
    "posting_price": 162.09524285,
    "close_price": 164.02494812,
    "percent_change": 1.19047619
  },
  {
    "title": "BME: Trading At A Historical Discount To NAV",
    "published": 1712317631,
    "posting_price": 162.09524285,
    "close_price": 164.02494812,
    "percent_change": 1.19047619
  },
  {
    "title": "UPDATE 1-Boehringer to lay off salespeople as Humira biosimilar sales lag",
    "published": 1712313544,
    "posting_price": 162.09524285,
    "close_price": 164.02494812,
    "percent_change": 1.19047619
  },
  {
    "title": "AbbVie\u2019s Humira outperforms forcing biosimilar maker to cut sales staff",
    "published": 1712302500,
    "posting_price": 162.09524285,
    "close_price": 164.02494812,
    "percent_change": 1.19047619
  },
  {
    "title": "Dividend Roundup: Citigroup, Mastercard, AT&T, PNC Financial, and more",
    "published": 1712300820,
    "posting_price": 162.09524285,
    "close_price": 164.02494812,
    "percent_change": 1.19047619
  },
  {
    "title": "Boehringer to lay off salespeople as Humira biosimilar sales lag",
    "published": 1712299144,
    "posting_price": 162.09524285,
    "close_price": 164.02494812,
    "percent_change": 1.19047619
  },
  {
    "title": "AbbVie Unusual Options Activity For April 05",
    "published": 1712287200,
    "posting_price": 162.09524285,
    "close_price": 164.02494812,
    "percent_change": 1.19047619
  },
  {
    "title": "Passive Income Perfection: 7 Dividend Stocks to Generate $50,000 Per Year",
    "published": 1712237312,
    "posting_price": 171.40607796,
    "close_price": 161.99876404,
    "percent_change": -5.48831992
  },
  {
    "title": "AbbVie to Host First-Quarter 2024 Earnings Conference Call",
    "published": 1712232000,
    "posting_price": 171.40607796,
    "close_price": 161.99876404,
    "percent_change": -5.48831992
  },
  {
    "title": "May 24th Options Now Available For AbbVie",
    "published": 1712223840,
    "posting_price": 171.40607796,
    "close_price": 161.99876404,
    "percent_change": -5.48831992
  },
  {
    "title": "Aldeyra gains as Perceptive Advisors boosts stake",
    "published": 1712222460,
    "posting_price": 171.40607796,
    "close_price": 161.99876404,
    "percent_change": -5.48831992
  },
  {
    "title": "Market Today: Meta Platforms Hits Record High Amid AI Optimism, AbbVie Adjusts Guidance",
    "published": 1712205660,
    "posting_price": 171.40607796,
    "close_price": 161.99876404,
    "percent_change": -5.48831992
  },
  {
    "title": "AbbVie slips after revising guidance to reflect earnings impact",
    "published": 1712196900,
    "posting_price": 171.40607796,
    "close_price": 161.99876404,
    "percent_change": -5.48831992
  },
  {
    "title": "AbbVie : Results of Operations and Financial Condition - Form 8-K",
    "published": 1712160498,
    "posting_price": 174.36820152,
    "close_price": 171.09735107,
    "percent_change": -1.87582966
  },
  {
    "title": "10 Health Care Stocks Whale Activity In Today's Session",
    "published": 1712148060,
    "posting_price": 174.36820152,
    "close_price": 171.09735107,
    "percent_change": -1.87582966
  },
  {
    "title": "2 Strong Dividend Buys And 2 Sells For Q2 2024",
    "published": 1712139180,
    "posting_price": 174.36820152,
    "close_price": 171.09735107,
    "percent_change": -1.87582966
  },
  {
    "title": "Allergan Aesthetics Announces the Return of CoolMonth with CoolSculpting\u00ae",
    "published": 1712133071,
    "posting_price": 174.36820152,
    "close_price": 171.09735107,
    "percent_change": -1.87582966
  },
  {
    "title": "Aldeyra gains as Oppenheimer upgrades on revised plans for lead asset",
    "published": 1712131620,
    "posting_price": 174.36820152,
    "close_price": 171.09735107,
    "percent_change": -1.87582966
  },
  {
    "title": "Vertex Is Worth Your Attention",
    "published": 1712131260,
    "posting_price": 174.36820152,
    "close_price": 171.09735107,
    "percent_change": -1.87582966
  },
  {
    "title": "Oppenheimer more bullish on Aldeyra, upgrades to Outperform",
    "published": 1712125680,
    "posting_price": 174.36820152,
    "close_price": 171.09735107,
    "percent_change": -1.87582966
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV) and AbbVie (ABBV)",
    "published": 1712118060,
    "posting_price": 174.36820152,
    "close_price": 171.09735107,
    "percent_change": -1.87582966
  },
  {
    "title": "The 3 Best Stocks to Buy in April 2024",
    "published": 1712085886,
    "posting_price": 173.08492197,
    "close_price": 174.3392334,
    "percent_change": 0.72467978
  },
  {
    "title": "US takes next step in Medicare drug price negotiations with pharma companies",
    "published": 1712076118,
    "posting_price": 173.08492197,
    "close_price": 174.3392334,
    "percent_change": 0.72467978
  },
  {
    "title": "NEXGEL, Inc. (NASDAQ:NXGL) Q4 2023 Earnings Call Transcript",
    "published": 1712068948,
    "posting_price": 173.08492197,
    "close_price": 174.3392334,
    "percent_change": 0.72467978
  },
  {
    "title": "AbbVie put volume heavy and directionally bearish",
    "published": 1712052960,
    "posting_price": 173.08492197,
    "close_price": 174.3392334,
    "percent_change": 0.72467978
  },
  {
    "title": "Got $3,000? 2 Monster Growth Stocks to Buy Right Now Without Hesitation",
    "published": 1712043360,
    "posting_price": 173.08492197,
    "close_price": 174.3392334,
    "percent_change": 0.72467978
  },
  {
    "title": "AbbVie Inc: An Exploration into Its Intrinsic Value",
    "published": 1712037660,
    "posting_price": 173.08492197,
    "close_price": 174.3392334,
    "percent_change": 0.72467978
  },
  {
    "title": "The 'Extremely Positive' Results That Helped Roivant Leapfrog Its 50-Day Line, Nearing A Breakout",
    "published": 1712034246,
    "posting_price": 173.08492197,
    "close_price": 174.3392334,
    "percent_change": 0.72467978
  },
  {
    "title": "A Deep Dive Into Investing Strategies For A Rich Retirement",
    "published": 1712029379,
    "posting_price": 173.08492197,
    "close_price": 174.3392334,
    "percent_change": 0.72467978
  },
  {
    "title": "AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know",
    "published": 1712007919,
    "posting_price": 175.48741383,
    "close_price": 174.4067688,
    "percent_change": -0.61579632
  },
  {
    "title": "Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study",
    "published": 1711989960,
    "posting_price": 175.48741383,
    "close_price": 174.4067688,
    "percent_change": -0.61579632
  },
  {
    "title": "NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year",
    "published": 1711972200,
    "posting_price": 175.48741383,
    "close_price": 174.4067688,
    "percent_change": -0.61579632
  },
  {
    "title": "Meet The \"Magnificent Seven\" of Healthcare Stocks",
    "published": 1711960200,
    "posting_price": 175.48741383,
    "close_price": 174.4067688,
    "percent_change": -0.61579632
  },
  {
    "title": "This Biopharma Stock Outperformed MSTR and SMCI in March 2024",
    "published": 1711947780,
    "posting_price": 175.48741383,
    "close_price": 174.4067688,
    "percent_change": -0.61579632
  },
  {
    "title": "This Biopharma Stock Outperforms MSTR and SMCI in March 2024",
    "published": 1711947540,
    "posting_price": 175.48741383,
    "close_price": 174.4067688,
    "percent_change": -0.61579632
  },
  {
    "title": "10 Dividend Growth Stocks: March 2024",
    "published": 1711943087,
    "posting_price": 175.48741383,
    "close_price": 174.4067688,
    "percent_change": -0.61579632
  },
  {
    "title": "AbbVie Inc. stock underperforms Monday when compared to competitors",
    "published": 1711942560,
    "posting_price": 175.48741383,
    "close_price": 174.4067688,
    "percent_change": -0.61579632
  }
]